ES2181928T3 - Derivados de diester de acido fosfonico. - Google Patents
Derivados de diester de acido fosfonico.Info
- Publication number
- ES2181928T3 ES2181928T3 ES96942639T ES96942639T ES2181928T3 ES 2181928 T3 ES2181928 T3 ES 2181928T3 ES 96942639 T ES96942639 T ES 96942639T ES 96942639 T ES96942639 T ES 96942639T ES 2181928 T3 ES2181928 T3 ES 2181928T3
- Authority
- ES
- Spain
- Prior art keywords
- phosphonic acid
- diester
- derivatives
- remedy
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 title 1
- -1 Phosphonic acid diester Chemical class 0.000 abstract 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 abstract 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 208000002177 Cataract Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 229930192474 thiophene Natural products 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
DERIVADOS DIESTER DEL ACIDO FOSFONICO REPRESENTADOS POR LA FORMULA GENERAL (1), LOS CUALES SON UTILES COMO REMEDIO PARA LA HIPERLIPIDEMIA Y DIABETES, COMO AGENTE ANTITUMORAL Y COMO AGENTE PREVENTIVO O CURATIVO DE LAS CATARATAS, EN LA QUE R 1 REPRESENTA CICLOALQUILO, ETC.; R 2 REPRESENTA HIDROGENO, FENILO O ALQUILO INFERIOR; R 3 Y R 4 REPRESENTA C ADA UNO DE ELLOS ALQUILO INFERIOR; Y A REPRESENTA UN HETEROCICLO SELECCIONADO ENTRE PIRAZINA, TIOFENO Y ANILLOS DE TIAZOL SUSTITUIDOS CON FENILO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34090995 | 1995-12-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2181928T3 true ES2181928T3 (es) | 2003-03-01 |
Family
ID=18341428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96942639T Expired - Lifetime ES2181928T3 (es) | 1995-12-27 | 1996-12-24 | Derivados de diester de acido fosfonico. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5985858A (es) |
EP (1) | EP0882730B1 (es) |
JP (1) | JP3500468B2 (es) |
KR (1) | KR100324866B1 (es) |
CN (1) | CN1070863C (es) |
AT (1) | ATE225357T1 (es) |
AU (1) | AU702980B2 (es) |
CA (1) | CA2241679C (es) |
DE (1) | DE69624143T2 (es) |
ES (1) | ES2181928T3 (es) |
TW (1) | TW438806B (es) |
WO (1) | WO1997024360A1 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4032193B2 (ja) * | 1998-04-24 | 2008-01-16 | 株式会社大塚製薬工場 | ホスホン酸ジエステル誘導体 |
CA2343027A1 (en) * | 1998-09-09 | 2000-03-16 | Metabasis Therapeutics, Inc. | Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
JP2003519154A (ja) * | 1999-12-22 | 2003-06-17 | メタバシス・セラピューティクス・インコーポレイテッド | 新規なビスアミダートホスホネートプロドラッグ |
US7563774B2 (en) * | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
WO2006023515A2 (en) * | 2004-08-18 | 2006-03-02 | Metabasis Therapeutics, Inc. | Novel thiazole inhibitors of fructose 1,6-bisphosphatase |
US20060090132A1 (en) * | 2004-10-26 | 2006-04-27 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Enhanced user assistance |
US8762839B2 (en) * | 2004-09-30 | 2014-06-24 | The Invention Science Fund I, Llc | Supply-chain side assistance |
US20060206817A1 (en) * | 2005-02-28 | 2006-09-14 | Jung Edward K | User assistance for a condition |
US9098826B2 (en) * | 2004-09-30 | 2015-08-04 | The Invention Science Fund I, Llc | Enhanced user assistance |
US9307577B2 (en) * | 2005-01-21 | 2016-04-05 | The Invention Science Fund I, Llc | User assistance |
US9038899B2 (en) * | 2004-09-30 | 2015-05-26 | The Invention Science Fund I, Llc | Obtaining user assistance |
US20060075344A1 (en) * | 2004-09-30 | 2006-04-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Providing assistance |
US10687166B2 (en) * | 2004-09-30 | 2020-06-16 | Uber Technologies, Inc. | Obtaining user assistance |
US8704675B2 (en) * | 2004-09-30 | 2014-04-22 | The Invention Science Fund I, Llc | Obtaining user assistance |
US8341522B2 (en) * | 2004-10-27 | 2012-12-25 | The Invention Science Fund I, Llc | Enhanced contextual user assistance |
US10514816B2 (en) | 2004-12-01 | 2019-12-24 | Uber Technologies, Inc. | Enhanced user assistance |
US20100223162A1 (en) * | 2004-09-30 | 2010-09-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Supply-chain side assistance |
US9747579B2 (en) | 2004-09-30 | 2017-08-29 | The Invention Science Fund I, Llc | Enhanced user assistance |
US20100146390A1 (en) * | 2004-09-30 | 2010-06-10 | Searete Llc, A Limited Liability Corporation | Obtaining user assestance |
US10445799B2 (en) | 2004-09-30 | 2019-10-15 | Uber Technologies, Inc. | Supply-chain side assistance |
US8282003B2 (en) * | 2004-09-30 | 2012-10-09 | The Invention Science Fund I, Llc | Supply-chain side assistance |
US8358976B2 (en) | 2006-03-24 | 2013-01-22 | The Invention Science Fund I, Llc | Wireless device with an aggregate user interface for controlling other devices |
US11100434B2 (en) | 2014-05-06 | 2021-08-24 | Uber Technologies, Inc. | Real-time carpooling coordinating system and methods |
US9552559B2 (en) | 2014-05-06 | 2017-01-24 | Elwha Llc | System and methods for verifying that one or more directives that direct transport of a second end user does not conflict with one or more obligations to transport a first end user |
US10458801B2 (en) | 2014-05-06 | 2019-10-29 | Uber Technologies, Inc. | Systems and methods for travel planning that calls for at least one transportation vehicle unit |
US9483744B2 (en) | 2014-05-06 | 2016-11-01 | Elwha Llc | Real-time carpooling coordinating systems and methods |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS636089A (ja) * | 1986-06-27 | 1988-01-12 | Nippon Shokubai Kagaku Kogyo Co Ltd | 石炭−水スラリ−用分散剤 |
JPH0651625B2 (ja) * | 1986-12-29 | 1994-07-06 | 株式会社大塚製薬工場 | 高脂質血症治療剤 |
JPH0745508B2 (ja) * | 1988-06-29 | 1995-05-17 | 株式会社大塚製薬工場 | カルボン酸アミド誘導体 |
AU606808B2 (en) * | 1988-06-29 | 1991-02-14 | Otsuka Pharmaceutical Factory, Inc. | Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same |
KR0185225B1 (ko) * | 1992-05-21 | 1999-05-15 | 오오쓰까 아끼히꼬 | 포스폰산 디에스테르 유도체 |
JP2787407B2 (ja) * | 1992-06-19 | 1998-08-20 | 株式会社大塚製薬工場 | ホスホン酸ジエステル誘導体 |
TW260664B (es) * | 1993-02-15 | 1995-10-21 | Otsuka Pharma Factory Inc | |
JP3156026B2 (ja) * | 1993-12-27 | 2001-04-16 | 株式会社大塚製薬工場 | ホスホン酸ジエステル誘導体 |
JP3109393B2 (ja) * | 1994-09-30 | 2000-11-13 | 双葉電子工業株式会社 | 可変周波数発生器 |
-
1996
- 1996-12-24 CA CA002241679A patent/CA2241679C/en not_active Expired - Fee Related
- 1996-12-24 KR KR1019980704945A patent/KR100324866B1/ko not_active IP Right Cessation
- 1996-12-24 US US09/091,946 patent/US5985858A/en not_active Expired - Fee Related
- 1996-12-24 WO PCT/JP1996/003775 patent/WO1997024360A1/ja active IP Right Grant
- 1996-12-24 AT AT96942639T patent/ATE225357T1/de not_active IP Right Cessation
- 1996-12-24 ES ES96942639T patent/ES2181928T3/es not_active Expired - Lifetime
- 1996-12-24 EP EP96942639A patent/EP0882730B1/en not_active Expired - Lifetime
- 1996-12-24 DE DE69624143T patent/DE69624143T2/de not_active Expired - Lifetime
- 1996-12-24 AU AU11734/97A patent/AU702980B2/en not_active Ceased
- 1996-12-24 CN CN96199436A patent/CN1070863C/zh not_active Expired - Fee Related
- 1996-12-24 JP JP52417697A patent/JP3500468B2/ja not_active Expired - Fee Related
- 1996-12-26 TW TW085116065A patent/TW438806B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5985858A (en) | 1999-11-16 |
JP3500468B2 (ja) | 2004-02-23 |
DE69624143T2 (de) | 2003-06-12 |
EP0882730A1 (en) | 1998-12-09 |
KR100324866B1 (ko) | 2002-10-19 |
AU1173497A (en) | 1997-07-28 |
WO1997024360A1 (fr) | 1997-07-10 |
TW438806B (en) | 2001-06-07 |
DE69624143D1 (de) | 2002-11-07 |
AU702980B2 (en) | 1999-03-11 |
CN1206419A (zh) | 1999-01-27 |
CA2241679A1 (en) | 1997-07-10 |
KR19990076819A (ko) | 1999-10-15 |
EP0882730B1 (en) | 2002-10-02 |
ATE225357T1 (de) | 2002-10-15 |
EP0882730A4 (en) | 1999-04-28 |
CN1070863C (zh) | 2001-09-12 |
CA2241679C (en) | 2002-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2181928T3 (es) | Derivados de diester de acido fosfonico. | |
AU680704B2 (en) | Cyclic amide derivatives | |
DE69840755D1 (de) | Pyridazinderivate und diese als aktiven bestandteil enthaltende medikamente | |
PT976748E (pt) | Derivados de pirrolidina com actividade inibidora de fosfolipase a2 | |
FI914187A0 (fi) | Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta | |
CA2103590A1 (en) | Benzamide derivative | |
PT916651E (pt) | DERIVADOS DE áCIDO FENILALQUILCARBOXILICO | |
AU767923C (en) | Novel 2-(N-cyanoimino)thiazolidin-4-one derivatives | |
AU755654C (en) | Novel amide compounds and drugs containing the same | |
DE60223904D1 (de) | Benzylaminanalogen | |
PT947504E (pt) | Derivados de vitamina d 16-eno | |
ATE223411T1 (de) | 1-methylcarbapenem-derivate | |
EP0807627A3 (en) | Anilide compounds as ACAT inhibitors | |
EP0921122A4 (en) | NEW EPOXYSUCCINAMIDE DERIVATIVES AND ASSOCIATED SALTS | |
DE60016384D1 (de) | Chondrogonese promotoren und indolin-2-on derivate | |
WO2003075928A3 (en) | Stable pharmaceutical compositions | |
GR3031390T3 (en) | Fluoropropene compound, an insecticide containing the same and an intermediate for production thereof | |
EP1197211A4 (en) | CANCER PREVENTION AND TREATMENT ACTIVE INGREDIENTS | |
ES2121036T3 (es) | Derivados de alquilenodiamina. | |
SE9402596D0 (sv) | Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa |